BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.

Autor: Cheng HH; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Medicine (Hematology and Oncology), University of Washington, Seattle., Shevach JW; Division of Medical Oncology, Duke University School of Medicine, Durham, North Carolina., Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Couch FJ; Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, New York., Domchek SM; Department of Medicine, Basser Center for BRCA and Abramson Cancer Center, University of Pennsylvania, Philadelphia., Eeles RA; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom., Giri VN; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut., Hall MJ; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania., King MC; Department of Medicine (Medical Genetics) and Department of Genome Sciences, University of Washington, Seattle., Lin DW; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Urology, University of Washington, Seattle., Loeb S; Department of Urology and Population Health, New York University School of Medicine, New York.; Department of Surgery/Urology, Manhattan Veterans Affairs, New York, New York., Morgan TM; Department of Urology, University of Michigan, Ann Arbor., Offit K; Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, New York, New York., Pritchard CC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle.; Brotman Baty Institute for Precision Medicine, Seattle, Washington., Schaeffer EM; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Szymaniak BM; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Vassy JL; Harvard Medical School at VA Boston Healthcare System, Boston, Massachusetts., Katona BW; Department of Medicine, Basser Center for BRCA and Abramson Cancer Center, University of Pennsylvania, Philadelphia., Maxwell KN; Department of Medicine, Basser Center for BRCA and Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Sep 01; Vol. 10 (9), pp. 1272-1281.

Utilization of genetic testing in men with advanced prostate cancer.

Autor: Aguiar JA; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Li EV; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Siddiqui MR; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Soliman MA; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Kumar SKSR; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Schaeffer EM; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Keeter MK; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Brown CH; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Szymaniak BM; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Ross AE; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Publikováno v: The Prostate [Prostate] 2023 May; Vol. 83 (6), pp. 516-523. Date of Electronic Publication: 2023 Jan 02.

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.

Autor: Weiss JM; University of Wisconsin Carbone Cancer Center., Gupta S; UC San Diego Moores Cancer Center., Burke CA; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Axell L; University of Colorado Cancer Center., Chen LM; UCSF Helen Diller Family Comprehensive Cancer Center., Chung DC; Massachusetts General Hospital Cancer Center., Clayback KM; Roswell Park Comprehensive Cancer Center., Dallas S; Lynch Syndrome International., Felder S; Moffitt Cancer Center., Gbolahan O; O'Neal Comprehensive Cancer Center at UAB., Giardiello FM; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Grady W; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance., Hall MJ; Fox Chase Cancer Center., Hampel H; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Hodan R; Stanford Cancer Institute., Idos G; City of Hope National Medical Center., Kanth P; Huntsman Cancer Institute at the University of Utah., Katona B; Abramson Cancer Center at the University of Pennsylvania., Lamps L; University of Michigan Rogel Cancer Center., Llor X; Yale Cancer Center/Smilow Cancer Hospital., Lynch PM; The University of Texas MD Anderson Cancer Center., Markowitz AJ; Memorial Sloan Kettering Cancer Center., Pirzadeh-Miller S; UT Southwestern Simmons Comprehensive Cancer Center., Samadder NJ; Mayo Clinic Cancer Center., Shibata D; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center., Swanson BJ; Fred & Pamela Buffett Cancer Center., Szymaniak BM; Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Wiesner GL; Vanderbilt-Ingram Cancer Center., Wolf A; Duke Cancer Institute., Yurgelun MB; Dana-Farber/Brigham and Women's Cancer Center., Zakhour M; UCLA Jonsson Comprehensive Cancer Center; and., Darlow SD; National Comprehensive Cancer Network., Dwyer MA; National Comprehensive Cancer Network., Campbell M; National Comprehensive Cancer Network.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2021 Oct 15; Vol. 19 (10), pp. 1122-1132. Date of Electronic Publication: 2021 Oct 15.

Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.

Autor: Szymaniak BM; Department of Urology, Feinberg School of Medicine at Northwestern University, Chicago, IL., Facchini LA; Seattle Cancer Care Alliance, Seattle, WA., Giri VN; Thomas Jefferson University, Philadelphia, PA., Antonarakis ES; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Carlo MI; Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY., Danila DC; Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY., Dhawan M; Division of Hematology/Oncology, University of California San Francisco, CA., George D; Division of Medical Oncology, Department of Medicine, and Duke Cancer Institute, Duke University Medical Center, Durham, NC., Graff JN; Division of Hematology and Medical Oncology, VA Portland Health Care System/Oregon Health & Science University Knight Cancer Institute, Portland, OR., Gupta S; Division of Hematology, Oncology, and Transplantation, University of Minnesota Masonic Cancer Center, Minneapolis, MN., Heath E; Karmanos Cancer Institute and Department of Oncology, Wayne State University, Detroit, MI., Higano CS; Fred Hutchinson Cancer Research Center and Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA., Liu G; University of Wisconsin, Madison, WI., Molina AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY., Paller CJ; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Patnaik A; Department of Medicine, University of Chicago Comprehensive Cancer Center, Chicago, IL., Petrylak DP; Department of Urology, Yale Cancer Center, New Haven, CT., Reichert Z; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Rettig MB; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA., Ryan CJ; Division of Hematology, Oncology, and Transplantation, University of Minnesota Masonic Cancer Center, Minneapolis, MN., Taplin ME; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA., Vinson J; The Prostate Cancer Clinical Trials Consortium, New York, NY., Whang YE; Department of Medicine, Hematology/Oncology, University of North Carolina Lineberger Cancer Center, Chapel Hill, NC., Morgans AK; Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine at Northwestern University, Chicago, IL., Cheng HH; Fred Hutchinson Cancer Research Center and Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA., McKay RR; Department of Medicine, University of California at San Diego Moores Cancer Center, La Jolla, CA.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2020 Dec; Vol. 16 (12), pp. 811-819. Date of Electronic Publication: 2020 Sep 28.